Elger W, Fähnrich M, Beier S, Qing S S, Chwalisz K
Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1065-74. doi: 10.1016/s0002-9378(87)80134-5.
Three antiprogestogens of the RU 38.486, ZK 98.734, and ZK 98.299, were studied at different stages of pregnancy in the guinea pig. Treatment starting on postconception day 4 completely prevented nidation; all three compounds had comparable inhibitory potency. Treatment after nidation, starting on postconception day 8, induced decidual collapse and bleeding, but embryonic tissue was retained in nidation sites. In contrast to results in animals in nonfertile cycles, luteolysis was not induced, indicating that antiprogestogens lack the ability to induce uterine prostaglandin synthesis/liberation. On postconception day 43, RU 38.486 showed marginal abortifacient activity. The other compounds induced expulsion more rapidly and at a higher rate. The comparatively pronounced antiglucocorticoid activity of RU 38.486 may account for this difference. With RU 38.486, a high level of uterine prostaglandin sensitivity and a cervical ripening were induced consistently and fast; spontaneous labor, on the other hand, occurred after several days, if at all. Complete uterine evacuation was induced within hours by otherwise inactive doses of sulprostone in various combinations with ZK 98.299 RU 38.486 but surprisingly not with ZK 98.734. A single dose of ZK 98.299 induced an approximately thirtyfold increase in uterine prostaglandin sensitivity within 24 hours, exceeding that present before term, but did not induce spontaneous labor. This is evidence that endogenous prostaglandins were not activated, analogous to perinidation stages. Observation of antiluteolytic activity of antiprogestogens in nonpregnant animals is considered of major theoretical importance in this context. It seems that inhibition of progesterone leads to suppressed uterine prostaglandin liberation. The same effect in pregnancy could explain the inability of the uterus to expel a seriously compromised conceptus. In conclusion, we suggest that progesterone is a stimulator rather than a depressor of uterine prostaglandins in the late luteal phase and pregnancy. The ability of the conceptus to neutralize this stimulatory action of progesterone is considered to be essential for the rescue of the corpus luteum and uterine motor quiescence in the guinea pig. The clinical significance of these findings is that the high frequency of incomplete abortions and protracted, sometimes heavy bleeding in pregnant women treated with RU 38.486 may reflect decidual compromise and simultaneous uterine prostaglandin deficiency, as found in our animal model after progesterone blockage.
在豚鼠的不同孕期阶段,对RU 38.486、ZK 98.734和ZK 98.299这三种抗孕激素进行了研究。在受孕后第4天开始治疗可完全阻止着床;所有三种化合物具有相当的抑制效力。着床后,即受孕后第8天开始治疗,可诱导蜕膜塌陷和出血,但胚胎组织仍保留在着床部位。与处于非受孕周期动物的结果不同,未诱导黄体溶解,这表明抗孕激素缺乏诱导子宫前列腺素合成/释放的能力。在受孕后第43天,RU 38.486表现出微弱的堕胎活性。其他化合物诱导排出的速度更快且比例更高。RU 38.486相对明显的抗糖皮质激素活性可能解释了这种差异。使用RU 38.486时,可持续且快速地诱导子宫对前列腺素的高敏感性和宫颈成熟;另一方面,自发分娩即使发生也在数天后。在各种与ZK 98.299、RU 38.486联合使用的情况下,原本无活性剂量的舒前列素可在数小时内诱导子宫完全排空,但令人惊讶的是与ZK 98.734联合使用时却不行。单次剂量的ZK 98.299可在24小时内使子宫对前列腺素的敏感性增加约30倍,超过足月前的水平,但未诱导自发分娩。这证明内源性前列腺素未被激活,类似于着床前期阶段。在这种情况下,观察到抗孕激素在未孕动物中的抗黄体溶解活性具有重要的理论意义。似乎孕酮的抑制会导致子宫前列腺素释放受到抑制。在孕期出现同样的效果可以解释子宫无法排出严重受损的孕体。总之,我们认为在黄体后期和孕期,孕酮是子宫前列腺素的刺激物而非抑制剂。在豚鼠中,孕体中和孕酮这种刺激作用的能力被认为对于挽救黄体和子宫运动静止至关重要。这些发现的临床意义在于,用RU 38.486治疗的孕妇中不完全流产的高发生率以及迁延性、有时大量出血的情况,可能反映了蜕膜受损以及同时存在的子宫前列腺素缺乏,正如我们在动物模型中孕酮阻断后所发现的那样。